Dark Matter Blog
JULY 16, 2021
The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. I had a first-hand role in raising money from Wall Street by being part of an IPO roadshow as Synta went public in 2007.
Drug Discovery World
MAY 12, 2023
It could also be used to localise cytokines to cold tumours to activate an immune response, or radiotherapeutics to enhance cancer cell death. 2007 Oct 23;104(43):16793-7. The possibilities are vast. DDW Volume 24 – Issue 2, Spring 2023 References Kolb, Finn, Sharpless, Angew. 2001, 40, 2004-2021. Proc Natl Acad Sci U S A.
Expert insights. Personalized for you.
52 
Let's personalize your content